Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CABIN: Citalopram and Behavioural Activation in Low Mood
NCT05627154Completed
- Sponsor
- University of Oxford
- Start
- May 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of citalopram in major depressive disorder (MDD) (3 arms), sponsored by University of Oxford. Primary endpoint: Changes in emotional cognition. Started May 2021; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05627154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05627154.